Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
By reducing hunger and promoting a feeling of fullness, these drugs have been shown to facilitate significant weight loss, ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Perrigo intends to put focus at select retailers on over-the-counter medications that relieve the side effects of GLP-1 drugs ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...
With the American Heart Association (AHA) and American Stroke Association (ASA) updating their guidelines for preventing ...
Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.
SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found. Only 13 states currently allow Medicaid to cover treatment of obesity using ...
Kentucky, Alaska and Alabama are the three states where weight loss drugs are most used, and Hawaii, Arizona and Colorado sit at the other end of the spectrum, a report has revealed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback